Wird geladen...
Development of complement therapeutics for inhibition of immune-mediated red cell destruction
A major objective of my National Blood Foundation (NBF)-funded proposal was to produce recombinant soluble forms of a complement regulatory protein called complement receptor 1 (CR1) that carries the Knops blood group system antigens to perform antibody neutralization studies. By generating these re...
Gespeichert in:
| Veröffentlicht in: | Transfusion |
|---|---|
| 1. Verfasser: | |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2005
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4797633/ https://ncbi.nlm.nih.gov/pubmed/16086799 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1537-2995.2005.00526.x |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|